All posts tagged
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
New Dutch Biotech gets Funding to Find Genetic Off Switches
UPDATE: UK Cannabis Biotech ready for a Blockbuster in Rare Epilepsy
What Happens when the Immune System Attacks Life-Saving Drugs?
French Gene Therapy Biotech Raises a Huge €37.5M in Series A
Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn
More “FDA Love” for Cannabis Company with Orphan Drug Designation
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
A Potential First Treatment for a Rare Genetic Disease clears Phase I
How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
Gene Therapy Biotech Founded to Save the CEO’s Daughter Goes Public in France
Labiotech UG, All Rights Reserved -
Send this to friend